Pyxis Oncology is trading at $2.92 (+10.18%) as the stock rebounds from Friday’s pullback amid a broader risk-on tone in U.S. equities.
- The upward move appears driven by short-term technical buying following last week’s volatility.
- There are no new company-specific announcements, earnings updates, or regulatory catalysts reported in current sessions.